Acceptable Incremental Cost Effectiveness Ratio for Use of New Drugs, Cases in Statin Therapies
نویسندگان
چکیده
منابع مشابه
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
1. Gold R, et al. Multiple Sclerosis Journal 2015;21(1):57-66. 2. Fernández O, et al. ECTRIMS 2014; P065. [Cited 01/06/2015]. Available at: http://onlinelibrary.ectrims-congress.eu/ectrims/2014/ACTRIMSECTRIMS2014/63772/undefined 3. O’Connor P, et al. N Engl J Med 2011;365:1293-303. 4. Miller AE, et al. J Neurol 2014;261:1781-1788. 5. Vermersch P, et al. Mult Scler 2014;20(6):705-16. 6. Polman C...
متن کاملIncremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives.
In evaluating the cost/effectiveness of therapeutic interventions (e.g. those based on innovative drugs or on Class-III medical devices), two main pharmacoeconomic parameters have been used over the past decades: the incremental cost-effectiveness ratio (ICER [1–3]) and the net monetary benefit (NMB [4–6]). The ICER and the NMB share some common features because they both require a pre-defined ...
متن کاملCost-effectiveness of hypothetical new cancer drugs
Background: In the last decade, a number of new treatment modalities have been developed for patients with small cell lung cancer (SCLC). The clinical effects are encouraging, but little is known about the costs and cost-effectiveness of new drugs. Methods: A Markov chain model has been developed to project patient outcomes and costs for patients with advanced SCLC. All patients in the control ...
متن کاملFurthering benefit/risk ratio and cost effectiveness of anticancer drugs.
BACKGROUND In Russia, the incidence of melanoma is increasing steadily. The approved standard of specialized medical care for melanoma of the skin defined the range of drugs, recommended for the provision of quality health care. However, it appears that the most effective innovative and safe medicines are at the same time the most expensive drugs. The most important is the assessment of drug us...
متن کاملCost-effectiveness of statin therapy for primary prevention in a low-cost statin era.
BACKGROUND With wide availability of low-cost generics, primary prevention with statins has become less expensive. We projected the cost-effectiveness of expanded statin prescribing strategies using low-cost generics and identified conditions under which aggressive prescribing ceases to be cost-effective. METHODS AND RESULTS We simulated expanded statin prescribing strategies with the coronar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 2010
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi.130.1347